SCHEMBL17952346

SCHEMBL17952346

Cc1cccc(-c2ccccc2)c1N1c2ccc(C#N)c(C#N)c2N(C)[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ ALDH1A1 P00352 7/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ GRIA2 P42262 2/20 0.33
▸ GRIA4 P48058 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ AR P10275 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ TSHR P16473 1/20 0.31
▸ HPGD P15428 3/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ GALR3 O60755 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ LMNA P02545 2/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952487 0.91 SMN1; SMN2 (0.38) SMN1; SMN2HIF1AALDH1A1KDM4EGRIA2
SCHEMBL17952109 0.88 CYP1A2 (0.37) SMN1; SMN2HIF1ATDP1L3MBTL1AR
SCHEMBL17947419 0.87 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AALDH1A1KDM4EAR
SCHEMBL17952269 0.85 AR (0.35) SMN1; SMN2ALDH1A1KDM4EGRIA2GRIA4
SCHEMBL17952189 0.83 CYP1A2 (0.38) ALDH1A1KDM4ETDP1L3MBTL1AR
SCHEMBL17952111 0.82 TSHR (0.37) SMN1; SMN2HIF1AALDH1A1KDM4EL3MBTL1
SCHEMBL17952223 0.81 ALDH1A1 (0.35) ALDH1A1KDM4EGRIA2GRIA4TDP1
SCHEMBL17952347 0.81 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AALDH1A1KDM4EGRIA2
SCHEMBL17952097 0.81 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AALDH1A1KDM4EGRIA2
SCHEMBL17952527 0.81 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AALDH1A1KDM4EAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418569-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418569-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP2 SMN1; SMN2 3820/4885HIF1A 4782/4885ALDH1A1 1620/4885
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP2 SMN1; SMN2 3820/4885HIF1A 4782/4885ALDH1A1 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback